PG
Pradeep Govind Patil
About Pradeep Govind Patil
Data last updated:
Pradeep Govind Patil is a Whole-Time Director at Kgn Pharmaceuticals Private Limited (since 2015) and Director at Karlson & Gibson Pharmaceuticals Private Limited (since 2023). The companies operate in Pharma. The largest current company by reported revenue is Kgn Pharmaceuticals Private Limited at ₹51.45 Cr (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Kgn Pharmaceuticals Private Limited U24239MH2000PTC128154 | Whole-Time Director | 30 Sep 2015 | 2000 | ₹51.45 Cr (FY 2025) | Active |
 Karlson & Gibson Pharmaceuticals Private Limited U46497MH2023PTC414335 | Director | 23 Nov 2023 | 2023 | Active |
Board colleagues of Pradeep Govind Patil
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Pradeep Govind Patil
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Pradeep Govind Patil
Pradeep Govind Patil currently holds 2 directorships: Kgn Pharmaceuticals Private Limited (Whole-Time Director, since 30 Sep 2015, revenue ₹51.45 Cr (FY 2025)); Karlson & Gibson Pharmaceuticals Private Limited (Director, since 23 Nov 2023).
Pradeep Govind Patil was first appointed on 30 Sep 2015 as Whole-Time Director at Kgn Pharmaceuticals Private Limited. The most recent appointment on record is 23 Nov 2023 at Karlson & Gibson Pharmaceuticals Private Limited.
The current boards of Pradeep Govind Patil's companies include Khursheed Anwar Mohammad Ali Ansari (Kgn Pharmaceuticals Private Limited), Mohammed Sufyaan Khursheed Anwar Ansari (Kgn Pharmaceuticals Private Limited), Mohammed Usman Khursheed Anwar Ansari (Kgn Pharmaceuticals Private Limited), Faiz Maqsud Khan (Karlson & Gibson Pharmaceuticals Private Limited), Munazir Mahebul Sayyed (Karlson & Gibson Pharmaceuticals Private Limited), Shahil Amar Khan Pathan (Karlson & Gibson Pharmaceuticals Private Limited).